Testing effectiveness (Phase 2)Looking for participantsNCT05654506
What this trial is testing
Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
Who this might be right for
Proliferative Glomerulonephritis With Monoclonal IgG Deposits
Mayo Clinic 40